Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 4
2011 4
2012 3
2014 4
2015 4
2016 5
2017 10
2018 3
2019 3
2020 2
2021 3
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Jiménez N, Garcia de Herreros M, Reig Ò, Marín-Aguilera M, Aversa C, Ferrer-Mileo L, García-Esteve S, Rodríguez-Carunchio L, Trias I, Font A, Rodriguez-Vida A, Climent MÁ, Cros S, Chirivella I, Domènech M, Figols M, Carles J, Suárez C, Herrero Rivera D, González-Billalabeitia E, Cívico C, Sala-González N, Ruiz de Porras V, Ribal MJ, Prat A, Mellado B. Jiménez N, et al. Among authors: climent ma. Eur Urol Oncol. 2024 Mar 1:S2588-9311(24)00025-7. doi: 10.1016/j.euo.2023.12.012. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38429210 Free article.
Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.
Climent MÁ, Álvarez C, Morales R, Maroto P, Rodríguez-Vida A, Méndez-Vidal MJ, Del Muro XG, Puente J, Láinez N, Vázquez S, Castellano D, Lang CG, Wang J, di Pietro A, Davis C, Sanz-Castillo B, Bolós MV, Valderrama BP. Climent MÁ, et al. Clin Transl Oncol. 2023 Dec 15. doi: 10.1007/s12094-023-03358-4. Online ahead of print. Clin Transl Oncol. 2023. PMID: 38102374
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.
Juan Fita MJ, Anido Herranz U, Mendez-Vidal MJ, Gironés-Sarrió R, Muñoz-Langa J, Sepúlveda-Sánchez J, Mellado B, Alvarez-Fernandez C, Heras López L, López-Guerrero JA, García-Casado Z, Calatrava A, Ángel Climent M. Juan Fita MJ, et al. Among authors: angel climent m. Cancers (Basel). 2023 Oct 31;15(21):5223. doi: 10.3390/cancers15215223. Cancers (Basel). 2023. PMID: 37958398 Free PMC article.
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Macaulay VM, Lord S, Hussain S, Maroto JP, Jones RH, Climent MÁ, Cook N, Lin CC, Wang SS, Bianchini D, Bailey M, Schlieker L, Bogenrieder T, de Bono J. Macaulay VM, et al. Among authors: climent ma. Br J Cancer. 2023 Oct;129(6):965-973. doi: 10.1038/s41416-023-02380-1. Epub 2023 Aug 3. Br J Cancer. 2023. PMID: 37537253 Free PMC article. Clinical Trial.
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Jiménez N, Reig Ò, Marín-Aguilera M, Aversa C, Ferrer-Mileo L, Font A, Rodriguez-Vida A, Climent MÁ, Cros S, Chirivella I, Domenech M, Figols M, González-Billalabeitia E, Jiménez Peralta D, Rodríguez-Carunchio L, García-Esteve S, Garcia de Herreros M, Ribal MJ, Prat A, Mellado B. Jiménez N, et al. Among authors: climent ma. Cancers (Basel). 2022 Sep 29;14(19):4757. doi: 10.3390/cancers14194757. Cancers (Basel). 2022. PMID: 36230681 Free PMC article.
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
Garrido Siles M, López-Beltran A, Pelechano P, García Vicente AM, Gironés Sarrió R, González-Haba Peña E, Rodríguez Antolín A, Zapatero A, Arranz JÁ, Climent MÁ; Spanish Oncology Genitourinary Multidisciplinary Working Group. Garrido Siles M, et al. Among authors: climent ma. Cancers (Basel). 2022 Aug 17;14(16):3968. doi: 10.3390/cancers14163968. Cancers (Basel). 2022. PMID: 36010964 Free PMC article. Review.
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management.
Bellmunt J, Valderrama BP, Puente J, Grande E, Bolós MV, Lainez N, Vázquez S, Maroto P, Climent MÁ, Garcia Del Muro X, Arranz JÁ, Durán I. Bellmunt J, et al. Among authors: climent ma. Crit Rev Oncol Hematol. 2022 Jun;174:103683. doi: 10.1016/j.critrevonc.2022.103683. Epub 2022 Apr 16. Crit Rev Oncol Hematol. 2022. PMID: 35439541 Free article. Review.
Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group.
García-Del-Muro X, Durán I, Perez-Gracia JL, Ángel Climent M, Mellado B, Virizuela JA, Castellano DE, González Del Alba A, García Carbonero I, Álvarez-Fernández C, García-Donas J, Gil-Martin M, Hernández AG. García-Del-Muro X, et al. Among authors: angel climent m. Clin Genitourin Cancer. 2022 Aug;20(4):388.e1-388.e10. doi: 10.1016/j.clgc.2022.03.008. Epub 2022 Mar 18. Clin Genitourin Cancer. 2022. PMID: 35428584 Clinical Trial.
Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
González-Del-Alba A, Conde-Moreno AJ, García Vicente AM, González-Peramato P, Linares-Espinós E, Climent MÁ, The Sogug Multidisciplinary Working Group. González-Del-Alba A, et al. Among authors: climent ma. Cancers (Basel). 2022 Feb 23;14(5):1130. doi: 10.3390/cancers14051130. Cancers (Basel). 2022. PMID: 35267437 Free PMC article. Review.
51 results